Adherence to Antipsychotic Medication and Quality of Life in Latin-American Patients Diagnosed with Schizophrenia.
Alejandra Caqueo-UrízarAlfonso UrzúaPatricio Mena-ChamorroGuillaume FondLaurent BoyerPublished in: Patient preference and adherence (2020)
This study provides evidence of the association between adherence to treatment and quality of life in patients diagnosed with schizophrenia. Therefore, as in developed countries, improving adherence to antipsychotic medication would appear to be an important issue to address to improve patients' QoL in Latin American countries.